Indication and outcome of lupus anticoagulant and antiphospholipid antibodies testing in routine clinical practice.

Eva K KempersVirgil A S H DalmMarie Josee E van RijnAnnemarie G M G J MuldersFrank W G LeebeekMoniek P M de MaatArend Jan Gerard Jansen

Published in: Rheumatology advances in practice (2021)

The prevalence of one or more positive aPL test was 9.9% and APS was diagnosed in 3.5% of the patients. Patients with arterial thrombosis had significantly higher anti-β2GPI IgG and aCL IgG, which should be confirmed in future studies.

Keyphrases

clinical practice
systemic lupus erythematosus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
pulmonary embolism
venous thromboembolism
risk factors
disease activity